CROs offering Immunogenicity Assays (ADA / NAb) with Biologics (Monoclonal Antibodies)
22 published
22 published CROs match Immunogenicity Assays (ADA / NAb) and Biologics (Monoclonal Antibodies).
Locations in this set include United States, China, United Kingdom, Australia, Germany, and Netherlands.
Capabilities that show up most often in this set: Biomarker Assays, Bioanalysis, Ligand-Binding Bioanalysis (Large Molecule), Flow Cytometry Services, and LC-MS Bioanalysis (Small Molecule).
Matching companies
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
WuXi AppTecGlobal CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.
Markdown mirror: /explore/immunogenicity-assays/biologics-monoclonal-antibodies.md